Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	2298	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	2651	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	4078	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	4165	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	4424	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	4567	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	6739	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	6848	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	6907	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	6983	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	7030	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	7151	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	7340	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	8022	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	8054	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	8101	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	8505	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	9155	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	9339	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	9345	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	9656	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	9741	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	10047	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	10150	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	10185	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	10378	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	10713	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	10767	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	11026	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	11109	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	11273	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	11427	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	11451	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	12284	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	12315	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	12353	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	12358	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	12771	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	12974	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	13624	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	13858	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	13877	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	14308	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	14699	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	15127	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	15590	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	15616	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	15817	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	15945	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	17008	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	17350	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	17543	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	19493	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	20385	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	20654	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	21141	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	22994	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	23573	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	24440	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	25338	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-	26601	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	LEUCINE (CAS# 328-39-2); (M-H)-		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	2243265	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	2705984	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	2707245	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	2799171	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	2933810	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	3279839	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	3362125	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	3472951	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	5312024	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	5343429	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	5523321	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	6434379	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	6454444	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	6546815	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	6730945	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	6761186	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	6915874	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	6931950	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	6974154	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	7042958	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	7109831	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	7398580	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	7456803	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	7488268	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	7575478	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	7588158	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	7751688	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	7787026	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	7888641	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	7942815	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	7957762	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	8042635	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	8072360	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	8080800	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	8301596	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	8357612	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	8362222	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	8494721	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	8497562	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	8500224	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	8567987	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	8673699	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	8710501	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	8751549	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	8868074	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	9082202	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	9162453	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	9395062	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	9425271	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	9446846	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	9539995	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	9559789	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	9640118	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	9940843	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	9990457	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	10100000	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	10100000	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	10200000	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	10300000	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	10400000	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	10500000	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	10600000	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	11100000	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	11300000	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	11300000	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	11300000	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	11300000	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	11300000	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	11400000	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	11500000	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	11500000	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	11800000	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	11800000	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	12000000	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	12200000	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	12400000	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	12500000	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	12600000	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	12700000	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	13100000	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	13200000	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	13300000	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	13600000	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	13600000	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	13700000	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	13800000	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	14100000	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	14600000	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	14900000	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	14900000	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	15100000	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	15400000	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	16000000	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	17000000	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	17600000	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	17800000	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	19800000	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+H)+	23000000	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+NA)+	20059	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+NA)+	23881	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+NA)+	24761	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+NA)+	24765	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+NA)+	25974	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+NA)+	26014	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+NA)+	26480	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+NA)+	26835	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	LEUCINE (CAS# 328-39-2); (M+NA)+	27678	Peak area	Case	N	Exemestane	Black	3 Month	N	N

Return to search page